Clinical Trial Assessment of Intermittent and Continuous Infusion Dose of N-Acetylcysteine on Redox Status of the Body in Patients with Sepsis Admitted to the ICU

Abstract

Purpose:

Conflicting results exist regarding the efficacy of N-acetyl cysteine (NAC) in sepsis treatment. A pivotal factor affecting the therapeutic potency of NAC in sepsis is timing and dosing of its infusion. We aimed to assess the effect of NAC on redox status of patients with sepsis and to compare its efficacy in intermittent and continuous infusion with the objective of developing the infusion regimen and optimizing the timing.

Materials and Methods:

A prospective, randomized clinical trial was designed to compare the antioxidative effect of NAC in intermittent infusion group (IV: 25 mg/kg bolus and then 25 mg/kg/8 hours 3 times) and continuous infusion group (IV: 25 mg/kg bolus and then 75 mg/kg over 24 hours) in 60 critically ill patients with sepsis (20 patients in each group). Blood samples were collected immediately before and after intervention for total antioxidant capacity (TAC) and malondialdehyde (MDA) assessment.

Results:

N-acetyl cysteine considerably increased TAC levels in both intermittent (0.68 ± 0.60; P value = .036) and continuous (0.69 ± 0.64; P value = .015) infusion groups when compared to placebo (0.61 ± 0.10); however, the difference in TAC levels between the intermittent and the continuous infusion did not reach statistical significance (P value = .942). Likewise, NAC treatment decreased MDA levels in both intermittent (19.45 ± 4.18; P value = 0.001) and continuous (22.47 ± 6.68; P value = .002) infusion groups when compared to placebo (31.76 ± 11.06), while the difference in MDA levels between the intermittent and the continuous infusion did not reach statistical significance (P value = .481).

Conclusion:

Our data confirmed the antioxidative effect of NAC treatment in patients with sepsis, with no significant difference in intermittent and continuous infusion.

Keywords

sepsis N-acetyl cysteine oxidative stress antioxidant

Get full access to this article

View all access options for this article.

References

Singer

Deutschman

Seymour

, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–810.

Stearns-Kurosawa

Osuchowski

Valentine

Kurosawa

Remick

. The pathogenesis of sepsis. Annu Rev Pathol. 2011;6:19–48.

Marik

Taeb

. SIRS, qSOFA and new sepsis definition. J Thorac Dis. 2017;9(4):943.

Boomer

Green

Hotchkiss

. The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer? Virulence. 2014;5(1):45–56.

de Oliveira

YPA

Pontes-de-Carvalho

Couto

Noronha-Dutra

. Oxidative stress in sepsis. Possible production of free radicals through an erythrocyte-mediated positive feedback mechanism. Braz J Infect Dis. 2017;21(1):19–26.

Berger

Chioléro

. Antioxidant supplementation in sepsis and systemic inflammatory response syndrome. Crit Care Med. 2007;35(9):S584–S590.

Chertoff

. N-Acetylcysteine’s role in sepsis and potential benefit in patients with microcirculatory derangements. J Intensive Care Med. 2018;33(2):87–96. doi:10.1177/0885066617696850.

Goode

Cowley

Walker

Howdle

Webster

. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med. 1995;23(4):646–651.

Oudemans-van Straaten

Spoelstra-de Man

de Waard

. Vitamin C revisited. Crit Care. 2014;18(4):460.

10.

Atkuri

Mantovani

Herzenberg

. N-Acetylcysteine—a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol. 2007;7(4):355–359.

11.

Dilger

Baker

. Oral N-acetyl-l-cysteine is a safe and effective precursor of cysteine 1. J Anim Sci. 2007;85(7):1712–1718.

12.

Mokhtari

Afsharian

Shahhoseini

Kalantar

Moini

. A review on various uses of N-acetyl cysteine. Cell J (Yakhteh). 2017;19(1):11.

13.

Csontos

Rezman

Foldi

, et al. Effect of N-acetylcysteine treatment on oxidative stress and inflammation after severe burn. Burns. 2012;38(3):428–437.

14.

Fraga

Tomasi

Biff

, et al. The effects of N-acetylcysteine and deferoxamine on plasma cytokine and oxidative damage parameters in critically ill patients with prolonged hypotension: a randomized controlled trial. J Clin Pharmacol. 2012;52(9):1365–1372.

15.

Spapen

Zhang

Demanet

Vleminckx

Vincent

J-L

Huyghens

. Does N-acetyl-L-cysteine influence cytokine response during early human septic shock? Chest. 1998;113(6):1616–1624.

16.

Molnar

Shearer

Lowe

. N-Acetylcysteine treatment to prevent the progression of multisystem organ failure: a prospective, randomized, placebo-controlled study. Crit Care Med. 1999;27(6):1100–1104.

17.

Stipanuk

Caudill

. Biochemical, physiological and molecular aspects of human nutrition; 3rd ed. 2013. https://evolve.elsevier.com/cs/product/9781455746293?role=student

18.

Kerksick

Willoughby

. The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress. J Int Soc Sports Nutr. 2005;2(2):38.

19.

Huet

Cherreau

Nicco

, et al. Pivotal role of glutathione depletion in plasma-induced endothelial oxidative stress during sepsis. Crit Care Med. 2008;36(8):2328–2334.

20.

Ortolani

Conti

De gaudio

Moraldi

Cantini

Novelli

. The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock. Am J Respir Crit Care Med. 2000;161(6):1907–1911.

21.

Zhang

Spapen

Nguyen

Rogiers

Bakker

Vincent

. Effects of N-acetyl-L-cysteine on regional blood flow during endotoxic shock. Eur Surg Res. 1995;27(5):292–300.

22.

Paterson

Galley

Webster

. The effect of N-acetylcysteine on nuclear factor-κB activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis. Crit Care Med. 2003;31(11):2574–2578.

23.

Ritter

Andrades

Reinke

Menna-Barreto

Moreira

JCF

Dal-Pizzol

. Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis. Crit Care Med. 2004;32(2):342–349.

24.

Szakmany

Marton

Molnar

. Lack of effect of prophylactic N-acetylcysteine on postoperative organ dysfunction following major abdominal tumour surgery: a randomized, placebo-controlled, double-blinded clinical trial. Anaesth Intensive Care. 2003;31(3):267.

25.

Spapen

. N-acetylcysteine in clinical sepsis: a difficult marriage. Crit Care. 2004;8(4):229.

26.

Peake

Moran

Leppard

. N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock. Crit Care Med. 1996;24(8):1302–1310.

27.

Galley

Howdle

Walker

Webster

. The effects of intravenous antioxidants in patients with septic shock. Free Radic Biol Med. 1997;23(5):768–774.